Irinotecan Hydrochloride + Rifabutin Interaction
Contraindicatedinteraction on record
Description
Strong CYP3A4 inducer substantially reduces exposure to irinotecan and SN-38. Do not administer unless no therapeutic alternatives exist.
Mechanism
CYP3A4 enzyme induction
Source: NLP:irinotecan hydrochloride